Apellis Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Lackner Thomas A. | See Remarks | Award / Grant | 2,725 | — | — | 7,725 | Feb 10, 2020 |
| Perry Nicole D | Vice President - Finance | Award / Grant | 2,500 | — | — | 2,500 | Feb 10, 2020 |
| Celona Lucia | See Remarks | Award / Grant | 5,213 | — | — | 5,213 | Feb 10, 2020 |
| Deschatelets Pascal | Chief Operating Officer | Award / Grant | 9,375 | — | — | 891,118 | Feb 10, 2020 |
| SCHEIBLER LUKAS | See Remarks | Award / Grant | 9,375 | — | — | 12,310 | Feb 10, 2020 |
| Townsend Adam J. | See Remarks | Award / Grant | 9,375 | — | — | 9,375 | Feb 10, 2020 |
| Francois Cedric | Chief Executive Officer | Award / Grant | 34,375 | — | — | 1,066,805 | Feb 10, 2020 |
| Sullivan Timothy Eugene | Chief Financial Officer | Award / Grant | 11,688 | — | — | 23,387 | Feb 10, 2020 |
| Watson David O. | General Counsel | Option Exercise | 15,000 | $2.67 | $40,050 | 34,042 | Jan 27, 2020 |
| Francois Cedric | Chief Executive Officer | Option Exercise | 30,637 | $2.14 | $65,563 | 1,032,430 | Jan 16, 2020 |
| Machiels Alec | — | Sale | 2,500 | $41.47 | $103,675 | 669,544 | Jan 15, 2020 |
| Francois Cedric | Chief Executive Officer | Sale | 4,562 | $42.55 | $194,113 | 1,006,793 | Jan 15, 2020 |
| Morningside Venture Investments Ltd | — | Purchase | 540,540 | $37.00 | $19,999,980 | 12,556,342 | Jan 13, 2020 |
| Dunlop A. Sinclair | — | Sale | 25,890 | $28.55 | $739,160 | 374,791 | Dec 19, 2019 |
| Francois Cedric | Chief Executive Officer | Sale | 5,000 | $27.95 | $139,750 | 1,006,793 | Dec 16, 2019 |
| Francois Cedric | Chief Executive Officer | Sale | 5,000 | $27.28 | $136,400 | 1,011,793 | Nov 15, 2019 |
| Francois Cedric | Chief Executive Officer | Sale | 3,524 | $26.61 | $93,774 | 1,016,793 | Oct 15, 2019 |
| Deschatelets Pascal | Chief Operating Officer | Sale | 1,010 | $25.64 | $25,896 | 881,743 | Sep 25, 2019 |
| Deschatelets Pascal | Chief Operating Officer | Sale | 100 | $25.53 | $2,553 | 924,886 | Sep 23, 2019 |
| Francois Cedric | Chief Executive Officer | Sale | 4,740 | $26.56 | $125,894 | 1,022,053 | Sep 16, 2019 |
| Sullivan Timothy Eugene | Chief Financial Officer | Purchase | 11,699 | $29.71 | $347,577 | 11,699 | Aug 29, 2019 |
| Francois Cedric | Chief Executive Officer | Option Exercise | 37,505 | $2.67 | $100,138 | 1,026,793 | Aug 23, 2019 |
| Francois Cedric | Chief Executive Officer | Option Exercise | 10,000 | $2.14 | $21,400 | 999,288 | Aug 15, 2019 |
| Watson David O. | General Counsel | Option Exercise | 5,000 | $2.67 | $13,350 | 22,042 | Aug 7, 2019 |
| Francois Cedric | Chief Executive Officer | Option Exercise | 275,000 | $2.14 | $588,500 | 989,288 | Jun 27, 2019 |
| Morningside Venture Investments Ltd | — | Purchase | 441,176 | $17.00 | $7,499,992 | 12,015,802 | Mar 11, 2019 |
| Axon Steven | Chief Business Officer | Option Exercise | 11,500 | $2.59 | $29,785 | 50,110 | Nov 14, 2018 |
| Grossi Federico | See Remarks | Option Exercise | 6,250 | $3.20 | $20,000 | 22,456 | Nov 14, 2018 |
| Morningside Venture Investments Ltd | — | Purchase | 19,599 | $18.79 | $368,265 | 11,512,902 | Sep 20, 2018 |
| Morningside Venture Investments Ltd | — | Purchase | 60,000 | $18.09 | $1,085,400 | 11,493,303 | Sep 17, 2018 |
| Watson David O. | General Counsel | Option Exercise | 32,818 | $2.67 | $87,624 | 32,818 | Sep 14, 2018 |
| Watson David O. | General Counsel | Gift | 624 | — | — | — | May 29, 2018 |
| SCHEIBLER LUKAS | See Remarks | Purchase | 2,935 | $20.37 | $59,786 | 2,935 | May 24, 2018 |
| Francois Cedric | Chief Executive Officer | Other | 384,292 | — | — | 714,288 | May 7, 2018 |
| Machiels Alec | — | Other | 930 | — | — | 930 | May 7, 2018 |
| Grossi Federico | See Remarks | Other | 7,706 | — | — | 16,206 | May 7, 2018 |
| Dunlop A. Sinclair | — | Other | 94,357 | — | — | 280,728 | May 7, 2018 |
| Deschatelets Pascal | Chief Operating Officer | Other | 384,292 | — | — | 945,744 | May 7, 2018 |
| Grossi Federico | See Remarks | Option Exercise | 8,500 | $3.20 | $27,200 | 8,500 | Apr 11, 2018 |
| Axon Steven | Chief Business Officer | Option Exercise | 38,610 | $2.59 | $100,000 | 38,610 | Feb 20, 2018 |
| Hillhouse Capital Management, Ltd. | — | C | 2,098,581 | — | — | 2,098,581 | Nov 13, 2017 |
| Cormorant Global Healthcare Master Fund, LP | — | Purchase | 1,071,428 | $14.00 | $14,999,992 | 3,473,925 | Nov 13, 2017 |
| Dunlop A. Sinclair | — | C | 400,679 | — | — | 400,679 | Nov 13, 2017 |
| AJU IB Investment Co., Ltd. | — | C | 2,292,062 | — | — | 2,292,062 | Nov 13, 2017 |
| venBio Global Strategic Fund II L.P. | — | Purchase | 127,515 | $14.00 | $1,785,210 | 3,579,305 | Nov 13, 2017 |
| Morningside Venture Investments Ltd | — | C | 10,778,303 | — | — | 10,778,303 | Nov 13, 2017 |
| GELLERT MICHAEL E | — | C | 798,068 | — | — | 943,989 | Nov 13, 2017 |